globalchange  > 气候变化与战略
DOI: 10.1016/j.scib.2021.03.002
论文题名:
Complete biosynthesis of the potential medicine icaritin by engineered Saccharomyces cerevisiae and Escherichia coli
作者: Wang P.; Li C.; Li X.; Huang W.; Wang Y.; Wang J.; Zhang Y.; Yang X.; Yan X.; Wang Y.; Zhou Z.
刊名: Science Bulletin
ISSN: 20959273
出版年: 2021
语种: 英语
英文关键词: Biochemistry ; Biosynthesis ; Cytology ; Enzymes ; Escherichia coli ; Flavonoids ; Glucose ; Yeast ; Biosynthetic pathway ; Cerevisiae ; Clinical trial ; Epimedium ; Hepatocellular carcinoma ; Medicinal plants ; Microbial strain ; Prenylflavonoid ; Saccharomyces ; Yeast strain ; Genes
英文摘要: Icaritin is a prenylflavonoid present in the Chinese herbal medicinal plant Epimedium spp. and is under investigation in a phase III clinical trial for advanced hepatocellular carcinoma. Here, we report the biosynthesis of icaritin from glucose by engineered microbial strains. We initially designed an artificial icaritin biosynthetic pathway by identifying a novel prenyltransferase from the Berberidaceae-family species Epimedium sagittatum (EsPT2) that catalyzes the C8 prenylation of kaempferol to yield 8-prenlykaempferol and a novel methyltransferase GmOMT2 from soybean to transfer a methyl to C4’-OH of 8-prenlykaempferol to produce icaritin. We next introduced 11 heterologous genes and modified 12 native yeast genes to construct a yeast strain capable of producing 8-prenylkaempferol with high efficiency. GmOMT2 was sensitive to low pH and lost its activity when expressed in the yeast cytoplasm. By relocating GmOMT2 into mitochondria (higher pH than cytoplasm) of the 8-prenylkaempferol–producing yeast strain or co-culturing the 8-prenylkaempferol–producing yeast with an Escherichia coli strain expressing GmOMT2, we obtained icaritin yields of 7.2 and 19.7 mg/L, respectively. Beyond the characterizing two previously unknown plant enzymes and conducting the first biosynthesis of icaritin from glucose, we describe two strategies of overcoming the widespread issue of incompatible pH conditions encountered in basic and applied bioproduction research. Our findings will facilitate industrial-scale production of icaritin and other prenylflavonoids. © 2021 Science China Press
Citation statistics:
资源类型: 期刊论文
标识符: http://119.78.100.158/handle/2HF3EXSE/170427
Appears in Collections:气候变化与战略

Files in This Item:

There are no files associated with this item.


作者单位: CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China; University of Chinese Academy of Sciences, Beijing, 100049, China; Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences, Wuhan, 430074, China; School of Life Sciences, Henan University, Kaifeng, 475001, China; Key Laboratory of South China Agricultural Plant Molecular Analysis and Genetic Improvement, Center of Economic Botany/Core Botanical Gardens, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, 510650, China

Recommended Citation:
Wang P.,Li C.,Li X.,et al. Complete biosynthesis of the potential medicine icaritin by engineered Saccharomyces cerevisiae and Escherichia coli[J]. Science Bulletin,2021-01-01
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wang P.]'s Articles
[Li C.]'s Articles
[Li X.]'s Articles
百度学术
Similar articles in Baidu Scholar
[Wang P.]'s Articles
[Li C.]'s Articles
[Li X.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wang P.]‘s Articles
[Li C.]‘s Articles
[Li X.]‘s Articles
Related Copyright Policies
Null
收藏/分享
所有评论 (0)
暂无评论
 

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.